Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Microbix Biosystems Inc T.MBX

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s): MBXBF

Microbix Biosystems is engaged in research & development of biological products and technologies. It has a pipeline of products, including Virus Yield Enhancement Technology, Semen Sexing Technology and a thrombolytic drug, Kinlytic.
Price: $0.37 | Change: $-0.015 | % Change: -3.90%
Volume: 20,000 | Day High/Low: 0.395/0.37 | 52 Week High/Low: 0.57/0.12
top

Snapshot

Last Traded: April 17, 2014 11:35 Transaction Volume: 20,000
Open: $0.37 Previous Close: $0.385
Bid: $0.375 Ask: $0.395
Bid Size: 10,500 Ask Size: 4,500
Market Cap: $25.3m Shares Out: 68.5m
PE Ratio: 29.6 Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Opinion

Canadian Biotech comes back to life: A buyer's guide

Everything you could ever want to know about biotech, biomed and bio investments up north.

Tony Pullen   January 21, 2014
0 stars

Latest Bullboard Posts

  • To days Chart

    1 star

    Look like to me to-days chart shows buying opportunity? High volume also?

    1.5 stars


  • counting the days

    5 stars

    29 .....

    4.5 stars


  • RE:RE:Year end report

    2.5 stars

    Ooooooooops!  Wrong board.  Thanks for correcting me.  But, that is the rule isn't it?  Unaudited quarterly's have to be filed within 90...

    4 stars


  • RE:Year end report

    5 stars

    not refr. to MBX as they filed Dec 30th 2013 for the 2013 years end that was Sept 30th 2013  are you?? We just finished the second...

    4.5 stars


  • Year end report

    3 stars

    Aren't Canadian companies required to file their audited financial report within 120 days of their year end and the other quarterlies...

    4 stars